Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.3625
-0.0113 (-3.02%)
Official Closing Price
Updated: 8:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
16
17
Next >
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Awarded Board Approval for CYB003 Phase 1/2a Clinical Trial
June 10, 2022
Via
Investor Brand Network
Cybin Receives Institutional Review Board Approval for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder
June 09, 2022
From
Cybin Inc.
Via
Business Wire
New Study Suggests That MDMA May Decrease Fear, Boost PTSD Treatment
June 09, 2022
Via
Investor Brand Network
Takeaways from Benzinga’s Psychedelics Capital Conference
May 16, 2022
Via
Investor Brand Network
Study Discovers Mechanisms Behind Relapse After Treatment of MDD
May 12, 2022
Via
Investor Brand Network
New Research Finds That Individuals Prefer Guide with Personal Psilocybin Experience
June 07, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Acquisition of Entheon Biomedical’s DMT Clinical Study
June 07, 2022
Via
Investor Brand Network
Cybin Acquires DMT Clinical Study from Entheon Biomedical
June 07, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Adelia Has Reached Milestone Achievements
June 06, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievements
June 03, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) EMBARK Program Spotlighted in “Frontiers in Psychology” Article
June 03, 2022
Via
Investor Brand Network
Cybin Announces Roster of 28 Expert Faculty and Advisors for its EMBARK Psychedelic Facilitator Training Program
June 03, 2022
From
Cybin Inc.
Via
Business Wire
Cybin Announces Publication in Frontiers in Psychology Journal Introducing EMBARK, an Integrative Model of Psychedelic Therapy
June 02, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Host Webinar Delving into Psychedelics Landscape, Current and Emerging Therapeutics
June 02, 2022
Via
Investor Brand Network
Cybin to Host Key Opinion Leader Webinar on June 9, 2022
June 02, 2022
From
Cybin Inc.
Via
Business Wire
Oregon Adopts First Installment of Psilocybin Rules
June 01, 2022
Via
Investor Brand Network
How Your Mental Health May Benefit from a Digital Detox
May 31, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Completes Major Step in Advancement of CYB003 for the Treatment of Major Depressive Disorder
May 31, 2022
Via
Investor Brand Network
Exposures
Product Safety
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain
May 31, 2022
Via
Investor Brand Network
Exposures
COVID-19
Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human Trial of CYB003 for the Treatment of Major Depressive Disorder
May 31, 2022
From
Cybin
Via
Business Wire
VC Executive Shares Insights into Legal Psychedelics Landscape
May 27, 2022
Via
Investor Brand Network
Exposures
COVID-19
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Efforts Boosted by New Study Indicating Effectiveness of Psychedelic Compounds
May 26, 2022
Via
Investor Brand Network
CSIRO to Collaborate with Biotechnology Firms on Psychedelic Research
May 24, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Partners to Help Accelerate Regulatory Pathway of CYB003
May 23, 2022
Via
Investor Brand Network
Study Finds That Some Mental Disorders Share Genetic Profiles
May 20, 2022
Via
Investor Brand Network
Study Finds Mindfulness, Psychedelic Encounters Beneficial for Mental Well-Being
May 19, 2022
Via
Investor Brand Network
Study Finds Alcohol Cravings Get Stronger After Consumption during Withdrawal
May 17, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in May 18 NYSE Trading Bell Ceremony
May 17, 2022
Via
Investor Brand Network
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
May 17, 2022
From
Cybin Inc.
Via
Business Wire
Study Indicates People Are Cautious About Psilocybin Therapy, More Awareness Needed
May 11, 2022
Via
Investor Brand Network
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.